Florida Bladder Cancer Trends 1981 to 2004: Minimal Progress in Decreasing Advanced Disease
Authors:
- 1 February 2008
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 179 (2) , 491-495
Abstract
There are no accepted screening recommendations for bladder cancer, although the greatest risk factors for bladder cancer are identifiable and modifiable, ie tobacco exposure. Bladder cancer survival correlates highly with disease stage. We ascertained whether there have been any demographic changes in the stage at presentation and mortality of bladder cancer in Florida during the last 25 years. Data from Florida Cancer Data Registry were evaluated on all bladder cancer cases between 1981 and 2004. Cases were coded and analyzed as local, in situ or advanced (regional and distant) disease. Cases were stratified by demographic groups. The overall incidence of bladder cancer decreased slightly in the last 25 years from 24.3 to 20.5 cases per 100,000 population. Overall white and Hispanic males had an almost 3 and 2-fold incidence of bladder cancer, respectively, compared to that in black males. White females had an almost 2-fold increased incidence compared to black and Hispanic females. Advanced stage bladder cancer decreased minimally in the 25 years. White and black females had the smallest decrease in the annual percent change of advanced bladder cancer. There was only a minimal decrease in bladder cancer mortality rates in black and white but not Hispanic individuals. Despite knowledge of the main risk factors for bladder cancer there were only small decreases in the percent of patients presenting with advanced disease in Florida in the last 25 years. Thus, bladder cancer may be an appropriate cancer for increased public awareness campaigns and potentially targeted screening of high risk populations.Keywords
This publication has 18 references indexed in Scilit:
- Lack of Progress in Early Diagnosis of Bladder CancerUrology, 2007
- Are Patients Aware of the Association Between Smoking and Bladder Cancer?Journal of Urology, 2006
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- A SIDE BY SIDE COMPARISON OF CYTOLOGY AND BIOMARKERS FOR BLADDER CANCER DETECTIONJournal of Urology, 2004
- Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancerWorld Journal of Urology, 2004
- A COMPARISON OF CYTOLOGY AND FLUORESCENCE IN SITU HYBRIDIZATION FOR THE DETECTION OF UROTHELIAL CARCINOMAJournal of Urology, 2000
- Declining Rates of Extracapsular Extension After Radical Prostatectomy: Evidence for Continued Stage MigrationJournal of Clinical Oncology, 1999
- Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part I: Evidence of the Effects of Screening in Recent Prostate Cancer Incidence, Mortality, and Survival RatesJNCI: Journal of the National Cancer Institute, 1999
- Time Lag to Diagnosis of Bladder Cancer–Influence of Psychosocial Parameters and Level of Health-Care ProvisionScandinavian Journal of Urology and Nephrology, 1993
- Presenting Symptoms, Treatment Delay and Survival in Bladder CancerScandinavian Journal of Urology and Nephrology, 1983